Rixubis (nonacog gamma): Reviews and patient testimonials

/static/themes-v3/default/images/default/opinion/traitement/intro.jpg?1720004028

Medication indications

RIXUBIS 250 IU, 500 IU, 1000 IU, 2000 IU & 3000 IU powder and solvent for solution for injection

Treatment and prophylaxis of bleeding in patients with haemophilia B (congenital factor IX deficiency).

RIXUBIS is indicated in patients of all age groups.


Route of administration: Injectable
Molecule: nonacog gamma

Patients' opinions on Rixubis

In brief

General satisfaction level: Be the first to evaluate

Treatment's effectiveness: Be the first to evaluate

Ease of use: Be the first to evaluate

Adherence to prescription: Be the first to evaluate

Detected side effects: Be the first to evaluate

Improvement in the quality of life: Be the first to evaluate

1 = Not at all satisfied
10 = Extremely satisfied

1 = Not at all satisfied
10 = Extremely satisfied

1 = Not at all satisfied
10 = Extremely satisfied

1 = Never
10 = Always

1 = Not at all important
10 = Extremely important

1 = Not at all satisfied
10 = Extremely satisfied

Tips and advice of the community

Join Carenity and be the first to give your opinion on this medication.

Conditions related to this medication

Fact sheet

Haemophilia

See the fact sheet